Tagrisso 80 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F02V3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,876
Award facts
- Contract value 100% obligated
- $24,876.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24.88K delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Tagrisso 80 mg tablets (30-count units). This non-set-aside, firm fixed-price contract is scheduled for completion by January 28, 2026, with performance based in Conshohocken, Pennsylvania. Tagrisso is an oncology medication used in the treatment of certain lung cancers, reflecting the federal government's ongoing pharmaceutical procurement needs for military and veteran healthcare systems. The award represents a task order under AmerisourceBergen's broader relationship with the Defense Logistics Agency.
This delivery order operates under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with the Defense Logistics Agency's Troop Support Medical division valued at up to $999.99M through December 31, 2031. This comprehensive vehicle enables the supply of specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities to support military healthcare programs globally. AmerisourceBergen's status as a major pharmaceutical distributor and the non-set-aside nature of this award demonstrate the company's competitive capability to fulfill federal medical procurement requirements across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F02V3?
SPE2DR26F02V3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F02V3 worth?
The government has obligated $24,876 on SPE2DR26F02V3.
Is contract SPE2DR26F02V3 an order under another contract?
Yes. SPE2DR26F02V3 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F02V3 competed?
The extent of competition for SPE2DR26F02V3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award